Webinar on Biotechnology Patents at the US Supreme Court – Patent Docs
By Dr. Matthew Watson
Webinar on Biotechnology Patents at the US Supreme Court Patent Docs Dr. Noonan will discuss these cases and their effects on the biotechnology industry, particularly in view of recent trends at the Supreme Court regarding the scope of patenting, as well as discuss the Supreme Court's decision in Mayo Collaborative ... |
Biotechnology: Virtual reality – Nature.com
By Dr. Matthew Watson
Biotechnology: Virtual reality Nature.com Such is life at a 'virtual' biotechnology company, a lean, nimble model that is gaining popularity among cash-hungry start-ups. These companies consist of as few as one full-time employee who oversees a drug from preclinical development to tests in ... |
Biotechnology to fight air pollution – euronews
By Dr. Matthew Watson
euronews | Biotechnology to fight air pollution euronews Using biotechnology to fight pollution is the challenge for a European Union research project. Under the spotlight – a specific kind of moss. At the University of Freiburg in Germany, a team of biologists is growing moss, in a controlled environment ... |
Canadian research suggests drug options to mitigate symptoms of deadly Tay … – Regina Leader-Post
By Dr. Matthew Watson
Regina Leader-Post | Canadian research suggests drug options to mitigate symptoms of deadly Tay ... Regina Leader-Post The work was published in the journal Human Molecular Genetics. Tay-Sachs is a genetic condition that develops in children born to parents who are both carriers of the disease. It is found all over the world, but rates are particularly high among ... Readily-available drugs may reduce devastating symptoms of Tay-Sachs diseaseMedical Xpress |
The A Team: More than a dozen Bainbridge Spartans rise to the top of their class – Bainbridge Island Review
By Dr. Matthew Watson
The A Team: More than a dozen Bainbridge Spartans rise to the top of their class Bainbridge Island Review She intends to double major in molecular genetics and political science and minor in latin. She's even planning for more education after that. “I'm hopefully going to medical school, because I want to be a surgeon,” Papajani said. Her drive is an ... |
Gene discovery to avoid baby disease – ScienceAlert
By Dr. Matthew Watson
ScienceAlert | Gene discovery to avoid baby disease ScienceAlert WAIMR's Laboratory for Molecular Genetics, headed by UWA Winthrop Professor Nigel Laing and globally recognised for its research into an inherited condition known as nemaline myopathy, coordinated a worldwide research effort that led to the discovery ... |
What happened when I had my genome sequenced – The Guardian
By Dr. Matthew Watson
The Guardian | What happened when I had my genome sequenced The Guardian Howard Jacob, director of the Human and Molecular Genetics Center in Wisconsin shows Carole Cadwalladr how to use the MyGenome app on her iPad. Photograph: Brent Altomare. At the time, I fumed about that. The information is out there and very shortly ... |
Discovering 1 reason why swarming evolved offers tantalizing clues on how … – EurekAlert (press release)
By Dr. Matthew Watson
Discovering 1 reason why swarming evolved offers tantalizing clues on how ... EurekAlert (press release) "There are both costs and benefits to swarming and all other behaviors," said Christoph Adami, MSU professor of microbiology and molecular genetics. "The benefits are discussed all the time. But the litmus test is whether a behavior evolves because of ... |
Circadian Rhythms Play Role In Fighting Off Intestinal Bacterial Infections: Study – Huffington Post
By Dr. Matthew Watson
Circadian Rhythms Play Role In Fighting Off Intestinal Bacterial Infections: Study Huffington Post "Salmonella is a good pathogen to study what happens during infection," Manuela Raffatellu, an assistant professor of microbiology and molecular genetics at the university, said in a statement. "We think these findings may be broadly applicable to ... |
Cellular Dynamics: California Stem Cell Agency Recipient Plans $57 Million IPO
By Dr. Matthew Watson
beneficiary of more than $16 million from the California stem cell
agency today announced that it intends to go public to raise $57.3
million for its iPS cell ventures.
![]() |
Jamie Thomson UCSB photo |
International, Inc., and was co-founded by internationally known stem
cell scientist Jamie Thomson of the University of Wisconsin, who is
currently the company's chief scientific officer. Thomson is also a professor
at UC Santa Barbara, where he is co-director of the Center for Stem
Cell Biology and Engineering.
agency awarded a $16 million grant to Cellular Dynamics to derive
three iPS cell lines from 3,000 individuals as part of the agency's
stem cell banking initiative. (Here is a link to the grant review summary.)
filings that it also will be the prime subcontractor on a $10 million
grant that the Coriell Institute for Medical Research of Camden,
N.J., received in the agency's stem cell banking round. Cellular Dynamics said
some of the funds from the IPO will be used to complete its
California laboratory in leased space at the Buck Institute in
Novato, north of San Francisco.
and sold its first commercial product in 2010. It reported revenues
of $6.6 million in 2012 and losses of $22.3 million. It has 115
full-time and part-time employees worldwide.
“During 2011 and 2012, we had three
large biopharmaceutical customers that individually accounted for
greater than 10% of our total revenue in one or both years. Eli Lilly
and Company (Lilly) accounted for 10% of total revenue in 2011 and
18% of total revenue in 2012. Hoffmann-La Roche Inc. (Roche)
accounted for 13% of total revenue in 2011 and GlaxoSmithKline plc
(GSK) accounted for 11% of our total revenue in 2012.”
filings,
“Our total revenue grew from $2.6
million in 2011 to $6.6 million in 2012, an increase of 154%. This
growth was driven by a 247% increase in sales of our iCell products
which grew from $1.5 million in 2011 to $5.2 million in 2012. At
December 31, 2011, our backlog of revenue expected to be recognized
in 2012 was $1.1 million. At December 31, 2012, our backlog of
revenue expected to be recognized in 2013 had grown to $4.1 million.
“For the three months ended March 31,
2013 our total revenue was $2.4 million, an increase of 109% over the
corresponding period in 2012. This growth was driven primarily by an
increase in iCell product sales, which grew from $0.6 million for the
three months ended March 31, 2012 to $1.8 million for the three
months ended March 31, 2013, an increase of 173%.”
Cellular Dynamics and Japanese researcher Shinya Yamanaka, who won the Nobel Prize last year for discovering how to reprogram adult stem cells into pluripotent cells (the iPS process).
"A
recent question is the issue of who has the intellectual property
(IP) rights to iPS cell technology. People have told me in the
past that they wondered if Cellular Dynamics has unambiguous rights
to develop all of these iPS cell-based products."
“This (the IPO) looks to
be very interesting and could transform the field as it develops.”
was light, but is more expected to surface tomorrow. Here is a link to the only story that had surfaced as of this writing.
the offering.
Light Coverage of Cellular Dynamics IPO But One Exec Says It’s Good for Stem Cell Biz
By Dr. Matthew Watson
carried stories about the public stock offering announced yesterday
by Cellular Dynamics International, Inc., a Wisconsin firm that will
benefit to the tune of $16 million-plus from the California stem cell agency.
Journal Sentinel described the company, founded by stem cell pioneer
Jamie Thomson, as in the business of making “fully functioning human cells in industrial quantities.”
Journal in Madison, where the company is based, quoted Beth Donley,
chief executive of Stemina
Biomarker Discovery, as saying,
“It can’t help but increase the
value of other stem cell companies.”
University of Wisconsin in Madison and at UC Santa Barbara, and we
queried Dennis Clegg, co-director of the Center for Stem Cell
Biology and Engineering at UC Santa Barbara, about the school's
ties to Cellular Dynamics, which hopes to take in $57 million in its public offering.
Barbara has a collaboration with Cellular Dynamics and the University
of Wisconsin to develop a vision-restoring, stem-cell-based therapy
for people with advanced retinal diseases. That $900,000 effort is financed by the Foundation Fighting Blindness.
to Cellular Dynamics is for work at the stem cell bank being created
at the Buck Institute in Novato, north of San Francisco.
Pomeroy on Doing the Right Thing and Foster Care
By Dr. Matthew Watson
![]() |
Claire Pomeroy CIRM photo |
member of the governing board of the $3 billion California stem cell
agency, she also published an essay on the Huffington Post in which
she discussed fleeing from an abusive home at age 14.
dean of the medical school at UC Davis and now president of the Lasker Foundation in New York, wrote last month,
“For some children, the uncertainty
of life on the street is better than certainty of violence at home.
It was for me. At age 14, I escaped from an abusive home with no
money, nowhere to go and only the clothes I was wearing. I remember
staring into the night, standing somewhere between fear and freedom.
I became one of the millions of homeless teens, yet I was lucky
because foster care ultimately saved me.”“However, after an emergency
placement and three foster homes, the challenges were not over. At 17
I aged out of the foster care system early when my foster parents
moved out of state. On my own again, I had to find a job, a place to
live and finish high school. Then I climbed the next mountain to
graduate from college and medical school.”
publicly talking about her foster care experience. She said she is
doing so because “many people lack an understanding of
the harsh statistics and their impact on the country's future. The
nation faces a crisis that demands a call to action to start truly
caring about foster youth before it is too late.”
foster care system but said that many children, particularly minorities among others such as the disabled, were not as fortunate and “were failed by the system and society.” Pomeroy called them
“throwaway children” who were “robbed of their ideals, gave up
hope and struggled to find a reason to live.”
who “age out” of the system graduate from high school, she wrote. Only 3
percent to 11 percent earn a bachelor's degree. More than
400,000 children were in foster care in 2011 and have a one in 11 chance
of being homeless.
improvement of foster care across the country. “It is time to stop
forcing children to be the heroes of their own survival,” she
wrote. “Now is the time to do the right the right thing.”
grandchildren, one of whom was adopted out of foster care as a
toddler. The other was adopted at birth. Some of the siblings of
those two African-American children remain in foster care today.
Salvation, through avatars – China Daily
By Dr. Matthew Watson
China Daily | Salvation, through avatars China Daily Yet he has the attention, and in some cases the avid support, of august figures at Harvard University and the Massachusetts Institute of Technology and leaders in fields like molecular genetics and neuroprosthetics. Roughly 30 speakers from these and ... |
Puma Biotechnology Presents Positive PB272 Clinical Data at ASCO 2012 … – EON: Enhanced Online News (press release)
By Dr. Matthew Watson
Puma Biotechnology Presents Positive PB272 Clinical Data at ASCO 2012 ... EON: Enhanced Online News (press release) LOS ANGELES--(EON: Enhanced Online News)--Puma Biotechnology, Inc. (OTCBB: PBYI), a development stage biopharmaceutical company, announced that results from an ongoing Phase I clinical trial of its lead drug candidate PB272 (neratinib) given in ... |
bone marrow stem cells used for back pain – Video
By Dr. Matthew Watson
bone marrow stem cells used for back pain
Brenda Goodman writing in Healthday reported, "Medical researchers are trying a new treatment for low back pain. Their hope is that harvesting and then re-in...
By: Nathan Wei
Visit link:
bone marrow stem cells used for back pain - Video
Lewis County man hopes for stem cell therapy
By Dr. Matthew Watson
VANCEBURG | A Lewis County man is working his way toward stem cell therapy in an attempt to help him walk again.
Jennifer Richardson, a long-time friend of Anthony Schumacher, said Schumacher was involved in an accident in December 2012, which left him paralyzed.
According to Richardson, Schumacher was in a comma for a few days and has no memory of the accident.
"He was going to work when his tire blew out and he wrecked the car," Richardson said. "He was in a coma for days and when he woke up he was paralyzed from the belly button down and couldn't remember anything."
Tammy Moore, Schumacher's mother, said he keeps a positive attitude about his situation.
"He's a happy person," she said. "He works out everyday and tries to learn new things about his situation and the procedure."
Moore said she would like to see Schumacher get the therapy.
"I don't know a lot about it. I'm still learning about it," she said. "But, from what I've seen, it's a good thing that can help him get at least some of the feeling back, if not all. I want to see him get it, if it can help."
Schumacher said he looks forward to the possibility of the procedure, too.
"I'm hopeful," he said. "I want to get it done. I've been trying to do my research and I would like to do this."
View post:
Lewis County man hopes for stem cell therapy
Cell therapy may regenerate liver cells
By Dr. Matthew Watson
Washington, June 7 (IANS) Researchers have shown that cell therapy may be used in liver disease to regenerate liver cells, says a study.
Investigators discovered that a human embryonic stem cell can be differentiated into a previously unknown liver progenitor cell, an early offspring of a stem cell, and produce mature and functional liver cells, reports Science Daily.
"The discovery of the novel progenitor represents a fundamental advance in this field and potentially to the liver regeneration field using cell therapy," said the study's senior author, Valerie Gouon-Evans, PharmD, Ph.D., assistant professor in the Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, at the Icahn School of Medicine at Mount Sinai.
"Until now, liver transplantation has been the most successful treatment for people with liver failure, but we have a drastic shortage of organs. This discovery may help circumvent that problem."
The study has been published in the journal Cell Stem Cell Friday.
Go here to read the rest:
Cell therapy may regenerate liver cells
Thumb Arthroscopy with Stem Cell Therapy – Video
By Dr. Matthew Watson
Thumb Arthroscopy with Stem Cell Therapy
Hand surgeon Dr. Michael Fitzmaurice details the thumb arthroscopy procedure that he pioneered, involving an endoscopic approach and stem cell therapy (PRP) ...
By: Michael Fitzmaurice
Read more from the original source:
Thumb Arthroscopy with Stem Cell Therapy - Video
Fibroblast Growth Factor FGF Stem Cell Therapy – Video
By Dr. Matthew Watson
Fibroblast Growth Factor FGF Stem Cell Therapy
Fibroblast Growth Factor Heals Heart Tissue by Feeding Stem Cells present.
By: David Dolores
Read the original post:
Fibroblast Growth Factor FGF Stem Cell Therapy - Video
Genetic Engineering: Two Million People In 52 Countries March Against Monsanto – Center for Research on Globalization
By Dr. Matthew Watson
Genetic Engineering: Two Million People In 52 Countries March Against Monsanto Center for Research on Globalization Among the challenges facing agriculture are producing food for our growing population and reducing agriculture's footprint on the environment. While we respect each individual's right to express their point of view on these topics, we believe we are ... |